Samantha Meltzer-Brody Featured in National News Following FDA Approval of First Postpartum Depression Treatment

UNC participated in three clinical trials for the drug ZULRESSO, developed by Sage Therapeutics. Samantha Meltzer-Brody, MD, MPH, director of the Perinatal Psychiatry Program at the UNC SOM, was the academic principal investigator for the trials, which the FDA reviewed during its approval process for ZULRESSO.

Multiple outlets quoted Samantha Meltzer-Brody, MD, MPH, during their coverage of the FDA's approval of the first-ever drug specifically designed for treatment of postpartum depression.

Here is a look at some of the coverage:

Filed under: ,